New Delhi: A recent survey conducted by Medvarsityan EdTech platform reveals that majority of diabetologists and endocrinologists across India are eager for continuous skill development, particularly in emerging AI-powered tools for diabetes management.
Conducted in recognition of World Diabetes Day, the survey included more than 3,000 healthcare providers specializing in diabetes care.
According to the survey, 90 percent of respondents emphasized the urgent need for continued training to improve diabetes management skills. The survey also highlights a preference for collaborative learning methods: 75 percent of participants prefer clinical case discussions and peer reviews to enhance their professional growth.
The study found that 82 percent of doctors prioritize learning about the prevention and management of diabetes complicationssuch as neuropathy and nephropathy. Advanced insulin management is also a key area of interest, with 78% of respondents interested in improving their expertise in this field.
There is also great demand to learn how to use AI-powered tools in diabetes care. Seventy-eight percent of healthcare professionals expressed interest in automated insulin dose calculators75 percent in continuous glucose monitoring (CGM) and 70 percent on diabetic retinopathy screening tools.
Despite this strong interest, healthcare professionals face several barriers to skill development. The top challenges were identified as time constraints (65 percent), program costs (60 percent), and work-life balance (58 percent).
The survey results also indicate growing interest in the role of AI in diabetes care. Eighty-eight percent of physicians see early detection of complications as a primary application of AI, and 85 percent anticipate benefits in personalized treatment planning. Additionally, 80 percent of respondents recognized the importance of automated blood sugar monitoring, supported by AI, to improve ongoing monitoring and control of diabetes.
Highlighting the transformative potential of AI in diabetes care, Gerald Jaideep, CEO of Medvarsity, said: “We are witnessing a fundamental transformation in diabetes care that will reshape the future of medical practice. The convergence of “AI technology and clinical experience represents more than just a technological upgrade; it is a complete paradigm shift in patient care.”
